RF-Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Dermatology

Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer. Although most cases follow an indolent course, a subset of patients may develop locally advanced or metastatic disease. This review provides a comparative […]

Immune checkpoint inhibitors (ICIs) have significantly advanced the treatment of cancer. They are not, however, free of adverse effects. These effects are called immune-related adverse events (irAEs) and often involve the skin. Most of the […]